1. Home
  2. FRAF vs IMRX Comparison

FRAF vs IMRX Comparison

Compare FRAF & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Financial Services Corporation

FRAF

Franklin Financial Services Corporation

HOLD

Current Price

$61.09

Market Cap

263.9M

Sector

Finance

ML Signal

HOLD

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$4.42

Market Cap

265.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRAF
IMRX
Founded
1906
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
263.9M
265.3M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
FRAF
IMRX
Price
$61.09
$4.42
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$17.20
AVG Volume (30 Days)
13.4K
2.0M
Earning Date
04-23-2026
05-04-2026
Dividend Yield
2.46%
N/A
EPS Growth
88.84
37.75
EPS
1.48
N/A
Revenue
N/A
N/A
Revenue This Year
$14.44
N/A
Revenue Next Year
$6.95
N/A
P/E Ratio
$41.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$34.50
$2.87
52 Week High
$62.84
$10.08

Technical Indicators

Market Signals
Indicator
FRAF
IMRX
Relative Strength Index (RSI) 59.47 45.75
Support Level $54.80 $3.95
Resistance Level $62.84 $5.36
Average True Range (ATR) 1.85 0.29
MACD 0.16 0.04
Stochastic Oscillator 77.15 65.66

Price Performance

Historical Comparison
FRAF
IMRX

About FRAF Franklin Financial Services Corporation

Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking, and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals, and governmental entities, which include accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: